On a recent episode of the American Academy of Ophthalmology’s “Experts InSight” podcast, Texas Retina’s Ashkan Abbey, MD, joined Ehsan Rahimy, MD, and host Jay Shridhar, MD, to discuss recent developments in the medical retina and injectable space, including biosimilars for ranibizumab and aflibercept, off-label bevacaziumb shortages, dry age-related macular degeneration (AMD) therapies and the new drug pipeline.
Click here to access the full podcast episode, “2025 Retina Update, Part 1: Injectables in the Medical Retina Space.”
About Dr. Abbey
Dr. Abbey serves as Texas Retina’s Director of Clinical Research for Dallas and cares for patients in our Dallas Main and Rockwall offices. Click here to learn more about him.